Integral Health Asset Management’s Arrowhead Research ARWR Stock Holding History

Integral Health Asset Management’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.3M	Sell	200,000 -100,000	-33%	-$7.39M	0.64%	44
2026 Q1	$18.8M	Buy	300,000 +200,000	+200%	+$12.7M	0.9%	28
2025 Q4	$6.64M	Sell	100,000 -125,000	-56%	-$6.13M	0.33%	66
2025 Q3	$7.76M	Buy	+225,000	New	+$4.95M	0.53%	60
2025 Q2	–	Sell	-175,000	Closed	-$2.23M	–	74
2025 Q1	$2.23M	Sell	175,000 -100,000	-36%	-$1.82M	0.24%	72
2024 Q4	$5.17M	Buy	+275,000	New	+$5.66M	0.44%	63
2022 Q1	–	Sell	-50,000	Closed	-$3.31M	–	76
2021 Q4	$3.31M	Buy	+50,000	New	+$3.44M	0.92%	36
2021 Q1	–	Sell	-50,000	Closed	-$3.84M	–	72
2020 Q4	$3.84M	Buy	+50,000	New	+$3.2M	1.14%	32

Other funds holding ARWR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Integral Health Asset Management's ARWR Position: Q2 2026 in Review

Integral Health Asset Management reduced its Arrowhead Research (ARWR) stake by 33% in Q2 2026, selling an estimated $7.39M and leaving 200,000 shares worth $16.3M. The position accounts for 0.64% of the portfolio, ranked #44.

Integral Health Asset Management first reported a position in ARWR in Q4 2020 and has held it in 8 quarters since. The position peaked at $18.8M in Q1 2026. 502 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

Integral Health Asset Management held 200,000 shares of Arrowhead Research worth $16.3M as of Q2 2026.
Integral Health Asset Management sold 100,000 Arrowhead Research shares in Q2 2026, an estimated $7.39M.
Arrowhead Research made up 0.64% of Integral Health Asset Management's portfolio in Q2 2026, its #44 holding.
Integral Health Asset Management first reported a position in Arrowhead Research in Q4 2020 and has held it in 8 quarters since.
Integral Health Asset Management's Arrowhead Research position peaked at $18.8M in Q1 2026.
502 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.